16th Jun 2026 12:13
(Sharecast News) - Inspiration Healthcare reported a 24% rise in revenue to £47.5m for the year ended 31 January on Tuesday, supported by strong growth in SLE products and £9.5m of one-off export revenues.
The AIM-traded neonatal medical technology group said gross profit rose 27% to £20.8m, while adjusted EBITDA improved to £2.8m from £0.2m and adjusted operating profit was £0.8m, compared with a £1.9m loss a year earlier.
Its operating loss narrowed to £0.1m from £14.7m, while net debt excluding leases fell 39% to £5.1m.
Chief executive Raffi Stepanian said FY26 had been a "transformational year" as the group moved from stabilisation to growth execution.
Inspiration said current trading was in line with board expectations for FY27, with its order book and opportunity pipeline supporting confidence in meeting full-year market forecasts.
At 1109 BST, shares in Inspiration Healthcare Group were up 7.31% at 27.9p.
Reporting by Josh White for Sharecast.com.
See latest RNS on Investegate